✦ LIBER ✦

O.475 Angiosarcoma of the head and neck. Review of 8 cases

✍ Scribed by D. Sauerborn; M. Virag

Book ID: 119581819
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 53 KB
Volume: 36
Category: Article
ISSN: 1010-5182
DOI: 10.1016/s1010-5182(08)71599-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Angiosarcoma of the head and neck: Revie

Angiosarcoma of the head and neck: Review of 11 cases

✍ William R. Panje; William J. Moran; David G. Bostwick; Victor V. Kitt 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB

Postirradiation angiosarcoma of the head

Postirradiation angiosarcoma of the head and neck: Report of a case

✍ Ann Marie Grady; Vejayan Krishnan; Leslie Cohen 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 352 KB

Angiosarcomas of the head and neck: a cl

Angiosarcomas of the head and neck: a clinico-immunohistochemical study of 8 consecutive patients

✍ X.J. Yang; J.W. Zheng; Q. Zhou; W.M. Ye; Y.A. Wang; H.G. Zhu; L.Z. Wang; Z.Y. Zh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Angiosarcomas of the head and neck: a cl

Angiosarcomas of the head and neck: a clinico-immunohistochemical study of 8 consecutive patients

✍ X.J. Yang; J.W. Zheng; Q. Zhou; W.M. Ye; Y.A. Wang; H.G. Zhu; L.Z. Wang; Z.Y. Zh 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 506 KB

Cutaneous angiosarcoma of the head and n

Cutaneous angiosarcoma of the head and neck: Report of 23 cases from a single institution

✍ Hugo Fontan Köhler; Rogério Izar Neves; Eduard Rene Brechtbühl; Nara Valeria Mat 📂 Article 📅 2008 🏛 SAGE Publications 🌐 English ⚖ 307 KB

Preoperative radiotherapy and bevacizuma

Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: Two case studies

✍ Bridget F. Koontz; Edward F. Miles; Mary Ann D. Rubio; John F. Madden; Samuel R. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

## Abstract ## Background. Angiosarcoma of the face is a vascular tumor with poor local control and short median survival despite standard treatment. Bevacizumab is a humanized monoclonal antibody to vascular endothelial growth factor (VEGF), which can inhibit tumor growth. It is synergistic with